NEW RIVER PHARMACEUTICALS INC 4
4 · NEW RIVER PHARMACEUTICALS INC · Filed Jan 31, 2007
Insider Transaction Report
Form 4
Krishnan Suma
Vice President, Product Dev.
Transactions
- Award
Stock Appreciation Right
2007-01-25+119,280→ 119,280 totalExercise: $56.39Exp: 2017-01-24→ Common Stock (119,280 underlying) - Award
Stock Appreciation Right
2007-01-25+178,920→ 178,920 total(indirect: By Spouse)Exercise: $56.39Exp: 2017-01-24→ Common Stock (178,920 underlying)
Footnotes (2)
- [F1]Half of these SARs are payable in cash and half are payable in restricted stock, which stock shall become vested and nonforfeitable on the second anniversary of the date of exercise of the SARs.
- [F2]Vests in three equal annual installments beginning on January 25, 2008, but at all times the exercise of the cash-based SARs will be subject to the satisfaction by the Issuer of a liquidity formula as a condition to exercise of such SARs. The vesting of these SARs will accelerate in the event of a change in control of the Issuer.